Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

HumaScan downgrades payment to Scantek:

This article was originally published in Clinica

Executive Summary

Following the FDA's warning letter to HumaScan last month over its BreastAlert differential temperature sensor for use as an adjunct in breast cancer detection, the company has announced changes to its US licensing deal with Scantek Medical. Scantek licenses the technology to HumaScan. The new arrangements include elimination of $450,000 in royalties due in the first two years of production, a further cancellation of $200,000 in connection with acquiring production machinery and a reduction of $375,000 in cash licence fees.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT081544

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel